Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT06793033

A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support

Led by neurescue · Updated on 2025-11-17

84

Participants Needed

2

Research Sites

86 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The NEURESCUE device is the first intelligent balloon catheter for aortic balloon occlusion (ABO), an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending to redirect blood flow towards the upper body. The purpose of this study is to compare the clinical safety and performance of Advanced Cardiovascular Life Support (ACLS) versus ACLS in combination with Aortic Balloon Occlusion (ABO) using the NEURESCUE device in subjects with cardiac arrest.

CONDITIONS

Official Title

A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 80 years
  • Cardiac arrest was witnessed
  • CPR started within 7 minutes of cardiac arrest
  • CPR duration less than 40 minutes at enrollment
  • Non-shockable heart rhythm
Not Eligible

You will not qualify if you...

  • Traumatic cardiac arrest
  • Known pregnancy
  • Known terminal disease
  • Known do-not-attempt-CPR order
  • Known opposition to study participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Charité - Universitätsklinikum Berlin

Berlin, Germany, 12203

Actively Recruiting

2

University Hospital Heidelberg

Heidelberg, Germany, 69120

Actively Recruiting

Loading map...

Research Team

M

Michael Preusch, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support | DecenTrialz